SAPHNELO
SAPHNELO
Approved
DIN Number
02522845
Drug Class
Human
Market Date
Mar 1, 2022
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02522845
AIG Number0163278001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AG11 ANIFROLUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:24.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
ANIFROLUMABActive
Strength: 150 MG / ML
Monograph: ANIFROLUMAB